Miglitol (Orient Pharma Co., Ltd.)
Welcome to the PulseAid listing for the Miglitol drug offered from Orient Pharma Co., Ltd.. This alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Orient Pharma Co., Ltd. |
NON-PROPRIETARY NAME: | Miglitol |
SUBSTANCE NAME: | MIGLITOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-07-31 |
END MARKETING DATE: | 0000-00-00 |
Miglitol HUMAN PRESCRIPTION DRUG Details:
Item Description | Miglitol from Orient Pharma Co., Ltd. |
LABELER NAME: | Orient Pharma Co., Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2015-07-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76333-125_71fe01c0-610b-477e-8709-d194ebde8624 |
PRODUCT NDC: | 76333-125 |
APPLICATION NUMBER: | ANDA203965 |
Other MIGLITOL Pharmaceutical Manufacturers / Labelers: